Hao Yang
Merck & Co.
14 Papers
50 Citations
Hao Yang is an academic researcher from Merck & Co.. The author has contributed to research in topics: Chemistry & Cycloaddition. The author has an hindex of 7, co-authored 13 publications. Previous affiliations of Hao Yang include University of Chicago & Codexis.
Chat about Author
Papers
Design of an in vitro biocatalytic cascade for the manufacture of islatravir
Mark A. Huffman,Anna Fryszkowska,Oscar Alvizo,Margie Borra-Garske,Kevin R. Campos,Canada Keith A,Paul N. Devine,Da Duan,Jacob Forstater,Shane T. Grosser,Holst M. Halsey,Gregory Hughes,Junyong Jo,Leo A. Joyce,Joshua N. Kolev,Jack Liang,Kevin M. Maloney,Benjamin F. Mann,Nicholas M. Marshall,Mark McLaughlin,Jeffrey C. Moore,Grant S. Murphy,Christopher C. Nawrat,Jovana Nazor,Scott J. Novick,Niki R. Patel,Agustina Rodriguez-Granillo,Sandra A. Robaire,Edward C. Sherer,Matthew D. Truppo,Aaron M. Whittaker,Deeptak Verma,Li Xiao,Yingju Xu,Hao Yang +34 more
TL;DR: An in vitro biocatalytic cascade synthesis of the investigational HIV treatment islatravir is reported, requiring fewer than half the number of steps of the previously reported routes.
492
Engineering a dirhodium artificial metalloenzyme for selective olefin cyclopropanation
TL;DR: This work covalently link an alkyne-substituted dirhodium catalyst to a prolyl oligopeptidase containing a genetically encoded L-4-azidophenylalanine residue to create an ArM that catalyses olefin cyclopropanation that reduces the formation of byproducts, including those resulting from the reaction of Dirhodium–carbene intermediates with water.
Engineered ribosyl-1-kinase enables concise synthesis of molnupiravir, an antiviral for covid-19
John A. McIntosh,Tamas Benkovics,Steven M. Silverman,Mark A. Huffman,Jongrock Kong,Peter E. Maligres,Tetsuji Itoh,Hao Yang,Deeptak Verma,Weilan Pan,Hsing-I Ho,Jonathan Vroom,Anders M. Knight,Jessica A. Hurtak,Artis Klapars,Anna Fryszkowska,William J. Morris,Neil A. Strotman,Grant S. Murphy,Kevin M. Maloney,Patrick S. Fier +20 more
TL;DR: In this paper, a short and sustainable synthesis of molnupiravir (MK-4482) from simple raw materials that would minimize the time needed to manufacture and supply moln upiravirus was proposed, enabled by the invention of a novel biocatalytic cascade featuring an engineered ribosyl-1kinase and uridine phosphorylase.
138
A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins
Anna Fryszkowska,Chihui An,Oscar Alvizo,Goutami Banerjee,Keith Canada,Yang Cao,Duane E. DeMong,Paul N. Devine,Da Duan,David Elgart,Iman Farasat,Donald R. Gauthier,Erin N. Guidry,Xiujuan Jia,Jongrock Kong,Nikki Kruse,Katrina W. Lexa,Alexey A. Makarov,Benjamin F. Mann,Erika M. Milczek,Vesna Mitchell,Jovana Nazor,Claudia Neri,Robert K. Orr,Peter Orth,Eric M. Phillips,James N. Riggins,Wes Schafer,Steven M. Silverman,Christopher A. Strulson,N Subramanian,Rama K. R. Voladri,Hao Yang,Jie Yang,Xiang Yi,Xiyun Zhang,Wendy Zhong +36 more
TL;DR: A bioconjugation strategy for modification of native peptides relying on high site selectivity conveyed by enzymes, and enzymatic activity on a range of bioactive peptides, suggesting that biocatalytic approaches may help in the development of potential peptide-based therapeutics or probes.
37
Pyridyl-substituted corrole isomers: synthesis and their regulation to G-quadruplex structures.
Heng Ma,Ming Zhang,Dan Zhang,Rong Huang,Yang Zhao,Hao Yang,Yijing Liu,Xiaocheng Weng,Yangyang Zhou,Minggang Deng,Liang Xu,Xiang Zhou +11 more
TL;DR: This study provides the first experimental insight into how selectivity might be achieved for different G-quadruplexes by a single group of methylpyridylium corrole isomers that may be optimized for potential selective cancer therapy.
29